20th Annual General Meeting – 2026
Vilin Bio Med Limited successfully convened its 20th Annual General Meeting on 2 September 2026 at 3:00 PM, bringing together the Company’s management and shareholders to review the Company’s performance and key developments during the year.
The Annual General Meeting provided an important platform for shareholder engagement and transparent communication, with the management presenting an overview of the Company’s financial performance, business progress, strategic initiatives and future growth priorities.
The Company continues to strengthen its position in the pharmaceutical sector with a focus on expanding its domestic and international presence, strengthening its business capabilities and pursuing new opportunities across global markets.
Looking ahead, Vilin Bio Med remains committed to building a sustainable, innovation-driven and globally connected pharmaceutical business. The Company’s strategic focus continues to be on operational excellence, responsible growth, strengthening stakeholder relationships and creating long-term value for shareholders.
The management expressed its sincere appreciation to all shareholders, employees, business partners, customers and other stakeholders for their continued trust, confidence and valuable support.
A Moment of Continued Growth and Partnership
